View in EDS

Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.

Saved in:
Bibliographic Details
Title: Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
Authors: Du XL; Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center at Houston, Houston, USA., Simpson LM; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA., Osani MC; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA., Yama JM; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA., Davis BR; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA.
Source: Journal of Alzheimer's disease & Parkinsonism [J Alzheimers Dis Parkinsonism] 2022; Vol. 12 (3). Date of Electronic Publication: 2022 Apr 22.
Publication Type: Journal Article
Journal Info: Publisher: OMICS Pub. Group Country of Publication: United States NLM ID: 101587593 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2161-0460 (Print) NLM ISO Abbreviation: J Alzheimers Dis Parkinsonism Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35571234
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Du+XL%22">Du XL</searchLink>; Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center at Houston, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Simpson+LM%22">Simpson LM</searchLink>; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Osani+MC%22">Osani MC</searchLink>; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Yama+JM%22">Yama JM</searchLink>; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Davis+BR%22">Davis BR</searchLink>; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101587593%22">Journal of Alzheimer's disease & Parkinsonism</searchLink> [J Alzheimers Dis Parkinsonism] 2022; Vol. 12 (3). <i>Date of Electronic Publication: </i>2022 Apr 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22OMICS+Pub%2E+Group%22">OMICS Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101587593 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2161-0460 (Print) <i>NLM ISO Abbreviation: </i>J Alzheimers Dis Parkinsonism <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35571234
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Du XL
      – PersonEntity:
          Name:
            NameFull: Simpson LM
      – PersonEntity:
          Name:
            NameFull: Osani MC
      – PersonEntity:
          Name:
            NameFull: Yama JM
      – PersonEntity:
          Name:
            NameFull: Davis BR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2161-0460
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of Alzheimer's disease & Parkinsonism
              Type: main
ResultId 1